Market Closed -
Borsa Istanbul
08:38:02 04/07/2024 pm IST
|
5-day change
|
1st Jan Change
|
16.05
TRY
|
-0.62%
|
|
-8.02%
|
+152.36%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
61.56
|
307.6
|
521.2
|
516
|
706
|
915.8
|
Enterprise Value (EV)
1 |
57.37
|
307.2
|
515
|
507.1
|
684.9
|
927.2
|
P/E ratio
|
5.03
x
|
21
x
|
18.8
x
|
13.7
x
|
12.5
x
|
6.38
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.72
x
|
6.26
x
|
8.03
x
|
6.04
x
|
5.51
x
|
3.67
x
|
EV / Revenue
|
1.61
x
|
6.26
x
|
7.93
x
|
5.93
x
|
5.34
x
|
3.71
x
|
EV / EBITDA
|
4.48
x
|
17.7
x
|
17
x
|
13.2
x
|
11.7
x
|
19.7
x
|
EV / FCF
|
-25.6
x
|
-57
x
|
-105
x
|
-40.8
x
|
-58.4
x
|
-29
x
|
FCF Yield
|
-3.91%
|
-1.75%
|
-0.95%
|
-2.45%
|
-1.71%
|
-3.45%
|
Price to Book
|
1.17
x
|
4.6
x
|
5.49
x
|
3.91
x
|
3.78
x
|
1.36
x
|
Nbr of stocks (in thousands)
|
1,44,000
|
1,44,000
|
1,44,000
|
1,44,000
|
1,44,000
|
1,44,000
|
Reference price
2 |
0.4275
|
2.136
|
3.619
|
3.583
|
4.903
|
6.360
|
Announcement Date
|
18/02/19
|
17/02/20
|
17/02/21
|
17/02/22
|
13/03/23
|
03/05/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
35.71
|
49.1
|
64.92
|
85.48
|
128.2
|
249.8
|
EBITDA
1 |
12.81
|
17.35
|
30.28
|
38.3
|
58.33
|
47.08
|
EBIT
1 |
11.83
|
16.18
|
28.75
|
35.19
|
55
|
25.24
|
Operating Margin
|
33.11%
|
32.96%
|
44.29%
|
41.17%
|
42.91%
|
10.1%
|
Earnings before Tax (EBT)
1 |
11.34
|
16.2
|
28.41
|
36.95
|
56.66
|
19.59
|
Net income
1 |
12.24
|
14.65
|
27.74
|
37.54
|
56.36
|
148.7
|
Net margin
|
34.26%
|
29.84%
|
42.73%
|
43.92%
|
43.98%
|
59.53%
|
EPS
2 |
0.0850
|
0.1017
|
0.1926
|
0.2607
|
0.3914
|
0.9971
|
Free Cash Flow
1 |
-2.241
|
-5.387
|
-4.899
|
-12.42
|
-11.72
|
-32
|
FCF margin
|
-6.28%
|
-10.97%
|
-7.55%
|
-14.52%
|
-9.15%
|
-12.81%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
18/02/19
|
17/02/20
|
17/02/21
|
17/02/22
|
13/03/23
|
03/05/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
11.3
|
Net Cash position
1 |
4.19
|
0.44
|
6.16
|
8.93
|
21.1
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
0.2409
x
|
Free Cash Flow
1 |
-2.24
|
-5.39
|
-4.9
|
-12.4
|
-11.7
|
-32
|
ROE (net income / shareholders' equity)
|
26.3%
|
24.5%
|
34.3%
|
33.1%
|
35.3%
|
24.7%
|
ROA (Net income/ Total Assets)
|
12%
|
13.3%
|
19.1%
|
14.7%
|
14.5%
|
2.12%
|
Assets
1 |
101.7
|
110.2
|
145.1
|
255.7
|
389.5
|
7,018
|
Book Value Per Share
2 |
0.3700
|
0.4600
|
0.6600
|
0.9200
|
1.300
|
4.680
|
Cash Flow per Share
2 |
0.0400
|
0.0200
|
0.0600
|
0.0900
|
0.1500
|
0.0700
|
Capex
1 |
2
|
1.11
|
0.21
|
1.48
|
1.17
|
5.8
|
Capex / Sales
|
5.61%
|
2.26%
|
0.33%
|
1.74%
|
0.91%
|
2.32%
|
Announcement Date
|
18/02/19
|
17/02/20
|
17/02/21
|
17/02/22
|
13/03/23
|
03/05/24
|
|
1st Jan change
|
Capi.
|
---|
| +152.36% | 7.15Cr | | +35.04% | 956.52Cr | | +33.03% | 443.01Cr | | -40.24% | 226.37Cr | | -9.44% | 160.39Cr | | -28.89% | 122.89Cr | | -43.59% | 96Cr | | -10.86% | 80Cr | | -49.77% | 73Cr | | -32.93% | 61Cr |
Medical Software & Technology Services
|